We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

54 hedge funds and large institutions have $2.84M invested in T2 Biosystems, Inc in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

133% more call options, than puts

Call options by funds: $21K | Put options by funds: $9K

7% less funds holding

Funds holding: 58 → 54 (-4)

9% less capital invested

Capital invested by funds: $3.12M → $2.84M (-$278K)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
4
Closed
11
Calls
$21K
Puts
$9K
Net Calls
+$12K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
+$374K
2
GCP
GSA Capital Partners
United Kingdom
+$257K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$84.8K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$57.9K
5
Morgan Stanley
Morgan Stanley
New York
+$40.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$73K
2
VF
Virtu Financial
New York
-$52K
3
Franklin Resources
Franklin Resources
California
-$41K
4
TRCT
Tower Research Capital (TRC)
New York
-$15K
5
Citadel Advisors
Citadel Advisors
Florida
-$13.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Courier Capital
New York
$9K – – –
Osaic Holdings
27
Osaic Holdings
Arizona
$9K +$3.95K +6 +55%
TSS
28
Two Sigma Securities
New York
$7K +$5.26K +8 +200%
GWM
29
Geneos Wealth Management
Colorado
$6K -$3.29K -5 -31%
CA
30
Continuum Advisory
Idaho
$6K – – –
PFGIA
31
Patriot Financial Group Insurance Agency
Massachusetts
$6K +$1.31K +2 +25%
AWM
32
AE Wealth Management
Kansas
$6K +$1.97K +3 +43%
TCM
33
Traynor Capital Management
Pennsylvania
$6K +$3.29K +5 +83%
FCMT
34
Founders Capital Management (Texas)
Texas
$5K – – –
LCS
35
Levin Capital Strategies
New York
$4K – – –
VFA
36
Valeo Financial Advisors
Indiana
$4K – – –
RJA
37
Raymond James & Associates
Florida
$3K -$1.97K -3 -38%
BAM
38
Brave Asset Management
New Jersey
$3K – – –
LPL Financial
39
LPL Financial
California
$3K – – –
Simplex Trading
40
Simplex Trading
Illinois
$3K +$3.95K +6 New
Cambridge Investment Research Advisors
41
Cambridge Investment Research Advisors
Iowa
$2K – – –
Creative Planning
42
Creative Planning
Kansas
$2K – – –
FWM
43
Focused Wealth Management
New York
$2K – – –
US Bancorp
44
US Bancorp
Minnesota
$2K – – –
MF
45
Meridian Financial
Massachusetts
$1.13K – – –
Bank of America
46
Bank of America
North Carolina
$1K -$658 -1 -33%
Credit Agricole
47
Credit Agricole
France
$1K – – –
IA
48
Inspire Advisors
Idaho
$1K – – –
MC
49
Moors & Cabot
Massachusetts
$1K – – –
NWA
50
Navis Wealth Advisors
New York
$1K – – –
1
2
3

TTOO Hedge Fund Activity: Q3 2022 in Review

54 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2022, worth a combined $2.84M — down 8.9% from $3.12M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of TTOO and 7 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 11 added.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $374K. The largest seller was Millennium Management, exiting entirely with an estimated $73K sold.

  • 54 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2022, down from 58 in Q2 2022.
  • Funds reported $2.84M of T2 Biosystems, Inc stock for Q3 2022, down 8.9% quarter-over-quarter.
  • 7 funds opened new T2 Biosystems, Inc positions in Q3 2022 and 11 closed out, a net change of -4 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2022 was Altium Capital Management, an estimated $374K added.
  • The largest T2 Biosystems, Inc seller in Q3 2022 was Millennium Management, an estimated $73K sold.

Based on aggregated 13F filings for Q3 2022.